Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

RC 3095

Known as: RC-3095 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
OBJECTIVE To evaluate the antiinflammatory effects of RC-3095 in 2 experimental models of arthritis, collagen-induced arthritis… Expand
2004
2004
Bombesin and its mammalian equivalent, gastrin-releasing peptide (GRP), stimulate cell proliferation and are involved in the… Expand
Highly Cited
1997
Highly Cited
1997
Antagonists of bombesin/gastrin-releasing peptide (BN/GRP) have been developed to inhibit the stimulatory effects of BN/GRP on… Expand
Highly Cited
1994
Highly Cited
1994
In this study, we investigated the effect of bombesin/GRP antagonist RC-3095 on the growth of CFPAC-1 human pancreatic cancer… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
1993
Highly Cited
1993
Nude mice bearing xenografts of the androgen‐independent human prostate‐cancer cell line PC‐3 were treated for 4 weeks with… Expand
Highly Cited
1992
Highly Cited
1992
Recently, it was reported that bombesin/gastrin-releasing peptide (GRP) have mitogenic effects on some human breast cancer cell… Expand
Highly Cited
1992
Highly Cited
1992
The effects of treatment with a bombesin receptor antagonist [D‐Tpi6, Leu13Ψ(CH2NH) Leu14]BN(6–14)(RC‐3095) and the combination… Expand
Highly Cited
1992
Highly Cited
1992
BACKGROUND Many breast cancers are estrogen independent, and even in patients who initially respond to estrogen suppression… Expand
Highly Cited
1991
Highly Cited
1991
Nude mice bearing xenografts of HT-29 human colon cancer cell line were treated for 4 weeks with a [D-Trp6] agonist of… Expand
Highly Cited
1991
Highly Cited
1991
Female Syrian golden hamsters with N-nitrosobis(2-oxopropyl)amine-induced pancreatic cancers were treated for 2 months with new… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2